Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
biotech
deals
fda
life sciences
national blog main
boston blog main
boston top stories
clinical trials
23andme
alexion pharmaceuticals
alirocumab
alnylam pharmaceuticals
amgen
amyotrophic lateral sclerosis (als)
atea pharmaceuticals
autoimmune disorders
boston
business
complement system
coronavirus
covid-19
disease
dna
drugs
evolocumab
food and drug administration
generalized myasthenia gravis
genetics
glaxosmithkline
gsk
immune-mediated necrotizing myopathy
inclisiran
medical device
medicine
national top stories
new york
new york blog main
new york top stories
novartis
parkinsons
What
deal
6
×
drug
6
×
disease
medicine
medicines
new
pharmaceuticals
ready
accelerate
acquire
adherence
agreed
alternative
andme’s
announced
antiviral
atea
autoimmune
billion
breakthrough
brings
building
cabinet
candidate
cash
change
cholesterol
company
compound
coronavirus
cure
currently
developer
developme
development
dna
established
expensive
far
fda
Language
unset
Current search:
deal
×
drug
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
UCB Stakes Out Autoimmune Territory With $2.1B Deal for Ra Pharma
@engadget.com
5 years ago
GSK to use 23andMe’s DNA library in drug development
@xconomy.com
5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
@WIRED
6 years ago
Meet the online pharmacy trying to solve the problem of drug adherence by simplifying your medicine cabinet.